Follow the 株式会社坪田ラボ stock price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社坪田ラボ has logged 7 reports. Market capitalisation: €6.7bn. The latest transaction was filed on 19 June 2026 (Holding update). Among the most active insiders: Kazuo Tsubota. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Tsubota Lab Co., Ltd. is a Japanese company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.